125 related articles for article (PubMed ID: 36641749)
1. Reversibility and developmental neuropathology of linear nevus sebaceous syndrome caused by dysregulation of the RAS pathway.
Kim YE; Kim YS; Lee HE; So KH; Choe Y; Suh BC; Kim JH; Park SK; Mathern GW; Gleeson JG; Rah JC; Baek ST
Cell Rep; 2023 Jan; 42(1):112003. PubMed ID: 36641749
[TBL] [Abstract][Full Text] [Related]
2. Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report.
Pan C; Zhou X; Hong A; Fang F; Wang Y
BMC Med Genomics; 2020 Dec; 13(1):188. PubMed ID: 33308209
[TBL] [Abstract][Full Text] [Related]
3. KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant.
Wang H; Qian Y; Wu B; Zhang P; Zhou W
BMC Med Genet; 2015 Oct; 16():101. PubMed ID: 26521233
[TBL] [Abstract][Full Text] [Related]
4. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
[TBL] [Abstract][Full Text] [Related]
5. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
6. Somatic KRAS mutation in an infant with linear nevus sebaceous syndrome associated with lymphatic malformations: A case report and literature review.
Lihua J; Feng G; Shanshan M; Jialu X; Kewen J
Medicine (Baltimore); 2017 Nov; 96(47):e8016. PubMed ID: 29381910
[TBL] [Abstract][Full Text] [Related]
7. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
8. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
Mitchell BJ; Rogers GF; Wood BC
J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.
Levinsohn JL; Tian LC; Boyden LM; McNiff JM; Narayan D; Loring ES; Yun D; Sugarman JL; Overton JD; Mane SM; Lifton RP; Paller AS; Wagner AM; Antaya RJ; Choate KA
J Invest Dermatol; 2013 Mar; 133(3):827-830. PubMed ID: 23096712
[No Abstract] [Full Text] [Related]
10. Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
Saraggi D; Salmaso R; Valentini E; Munari G; Vindigni V; Rugge M; Fassan M; Cerroni L
Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
[TBL] [Abstract][Full Text] [Related]
11. Identification of a recurrent mosaic
Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
[TBL] [Abstract][Full Text] [Related]
12. Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi.
Igawa S; Honma M; Minami-Hori M; Tsuchida E; Iizuka H; Ishida-Yamamoto A
J Dermatol; 2016 Jan; 43(1):103-4. PubMed ID: 26498739
[No Abstract] [Full Text] [Related]
13. Phacomatosis pigmentokeratotica: Postzygotic HRAS mutation with malignant degeneration of the sebaceous naevus.
Cranwell WC; Walsh M; Winship I
Australas J Dermatol; 2019 Aug; 60(3):e245-e246. PubMed ID: 30767209
[No Abstract] [Full Text] [Related]
14. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.
Minowa T; Kamiya T; Hida T; Okura M; Kato J; Idogawa M; Tange S; Hirano T; Tokino T; Uhara H
J Dermatol; 2021 Aug; 48(8):1268-1272. PubMed ID: 33908086
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
16. A Case of Apocrine Carcinoma Arising in a Sebaceous Naevus: Detection of HRAS G13R Mutation.
Katsuie S; Kiniwa Y; Mikoshiba A; Goto K; Okuyama R
Acta Derm Venereol; 2022 Apr; 102():adv00697. PubMed ID: 35393630
[No Abstract] [Full Text] [Related]
17. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
[TBL] [Abstract][Full Text] [Related]
18. Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.
Blanco Portals C; Gómez Tellado M; Del Pozo Losada J; Rodríguez Ruiz M
Clin Exp Dermatol; 2022 Jan; 47(1):235-239. PubMed ID: 34435383
[TBL] [Abstract][Full Text] [Related]
19. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
20. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome.
Sun BK; Saggini A; Sarin KY; Kim J; Benjamin L; LeBoit PE; Khavari PA
J Invest Dermatol; 2013 Mar; 133(3):824-827. PubMed ID: 23096709
[No Abstract] [Full Text] [Related]
[Next] [New Search]